In recent years, single-nucleotide polymorphism (SNP) arrays have been used to evaluate the incidence and prognostic significance of IKZF1 deletions in primary leukemic cells from pediatric patients with high-risk B-precursor ALL (BPL) [2-7]. This evidence concerns the gene IKZF1 and acute lymphoblastic leukemia.